Showing results (1-10 of 1,006) with videos related to
Sort By:
Pageof 101
The Journal of Clinical Investigation|March 1, 1982
Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasisY Sakata, N AokiThe Journal of Clinical Investigation|February 1, 1980
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factorY Sakata, N AokiBiochemical Genetics|October 1, 1984
Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: new methods for the detection of plasminogen variantsN Aoki, K Tateno, Y SakataThe Journal of Biological Chemistry|August 25, 1986
Conformation-specific monoclonal antibodies to the calcium-induced structure of protein CK Wakabayashi, Y Sakata, N AokiBlood|November 1, 1983
Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiencyN Aoki, Y Sakata, A IchinoseBlood|June 1, 1984
Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiencyY Sakata, J Mimuro, N AokiBibliotheca Haematologica|January 1, 1983
Treatment of DIC with antithrombin III concentratesY Sakata, N Yoshida, M Matsuda, et al.British Journal of Haematology|March 1, 1988
Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamideS Nakamura, A Kato, Y Sakata, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1982
Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active siteT Miyata, S Iwanaga, Y Sakata, et al.The Journal of Clinical Investigation|May 1, 1978
Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosisN Aoki, M Moroi, Y Sakata, et al.Pageof 101